New Combined Drug Regimen for Complete Cure of Pulmonary Tuberculosis in Patient with Impaired Hepatocellular Functioning – A Case Report
Soham Samajpaty
*
International Faculty, Department of General Medicine, Russian National Research Medical University named after NI Pirogov, Moscow, Russian Federation.
Gulnaz Minegalievna Ibragimova
Department of General Medicine, Russian National Research Medical University named after NI Pirogov, Moscow, Russian Federation.
*Author to whom correspondence should be addressed.
Abstract
The research gives new therapeutic regimen to Tuberculosis. Despite of the fact being that the current regimen is a burden on liver functioning; most of these are highly hepatotoxic and increases serum alanine aminotransferase (ALT) manifolds. In the backdrop of such a condition this clinical study has been done. Here 4 drugs has been selected and TB infection of a middle aged female patient was cured rapidly in one month who had hepatocellular changes. The regimen in this research has also showed significant improvement of liver functions post-therapy. This is about the “Mumbai Protocol” of tuberculosis management.
Keywords: Tuberculosis, Mycobacterium tuberculosis, Mumbai protocol, infection therapy